Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1391 ARTÍCULOS , VIENDO DEL 121 AL 135

Personality and dementia

Cipriani G, Borin G, Del Debbio A, Di Fiorino M.

J Nerv Ment Dis. 2015 Mar;203(3):210-4. doi: 10.1097/NMD.0000000000000264.

Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease Pathogenesis

Theofilas P, Dunlop S, Heinsen H, Grinberg LT.

J Alzheimers Dis. 2015;46(1):17-34. doi: 10.3233/JAD-142682.

Is Vasomotion in Cerebral Arteries Impaired in Alzheimer's Disease?

Di Marco LY, Farkas E, Martin C, Venneri A, Frangi AF.

J Alzheimers Dis. 2015;46(1):35-53. doi: 10.3233/JAD-142976.

Neurostimulation in Alzheimer's disease: from basic research to clinical applications

Nardone R, Höller Y, Tezzon F, Christova M, Schwenker K, Golaszewski S, Trinka E, Brigo F.

Neurol Sci. 2015 May;36(5):689-700. doi: 10.1007/s10072-015-2120-6. Epub 2015 Feb 27.

Comparison of Automated Brain Volume Measures obtained with NeuroQuant and FreeSurfer

Ochs AL, Ross DE, Zannoni MD, Abildskov TJ, Bigler ED; Alzheimer's Disease Neuroimaging Initiative.

J Neuroimaging. 2015 Sep-Oct;25(5):721-7. doi: 10.1111/jon.12229. Epub 2015 Feb 26.

Association of PS1 1/2, ACE I/D, and LRP C/T polymorphisms with Alzheimer's disease in the Chinese population: a meta-analysis of case-control studies

Yang L, Zhou HH, Ye YF, Fan XW, Wang YJ, Meng Y.

Genet Mol Res. 2015 Feb 6;14(1):1017-24. doi: 10.4238/2015.February.6.5.

Therapeutic approaches to modulating glutathione levels as a pharmacological strategy in Alzheimer's disease

Peter C, Braidy N, Zarka M, Welch J, Bridge W.

Curr Alzheimer Res. 2015;12(4):298-313. doi: 10.2174/1567205012666150302160308.

Vanutide cridificar and the QS-21 adjuvant in Japanese subjects with mild to moderate Alzheimer's disease: results from two phase 2 studies

Arai H, Suzuki H, Yoshiyama T.

Curr Alzheimer Res. 2015;12(3):242-54. doi: 10.2174/1567205012666150302154121.

Insulin resistance in Alzheimer disease: Is heme oxygenase-1 an Achille's heel?

Barone E, Butterfield DA.

Neurobiol Dis. 2015 Dec;84:69-77. doi: 10.1016/j.nbd.2015.02.013. Epub 2015 Feb 27.

Function of Nogo-A/Nogo-A receptor in Alzheimer's disease

Xu YQ, Sun ZQ, Wang YT, Xiao F, Chen MW.

CNS Neurosci Ther. 2015 Jun;21(6):479-85. doi: 10.1111/cns.12387. Epub 2015 Mar 2.

TNF-alpha G308A polymorphism and the susceptibility to Alzheimer's disease: an updated meta-analysis

Wang T.

Arch Med Res. 2015 Jan;46(1):24-30.e1. doi: 10.1016/j.arcmed.2014.12.006. Epub 2015 Feb 28.

Effect of the inhaled anesthetics isoflurane, sevoflurane and desflurane on the neuropathogenesis of Alzheimer's disease (review)

Jiang J, Jiang H.

Mol Med Rep. 2015 Jul;12(1):3-12. doi: 10.3892/mmr.2015.3424. Epub 2015 Mar 4.

Extracellular vesicles in Alzheimer's disease: friends or foes? Focus on aβ-vesicle interaction

Joshi P, Benussi L, Furlan R, Ghidoni R, Verderio C.

Int J Mol Sci. 2015 Mar 3;16(3):4800-13. doi: 10.3390/ijms16034800.

A second pedigree with amyloid-less familial Alzheimer's disease harboring an identical mutation in the amyloid precursor protein gene (E693delta)

Kutoku Y, Ohsawa Y, Kuwano R, Ikeuchi T, Inoue H, Ataka S, Shimada H, Mori H, Sunada Y.

Intern Med. 2015;54(2):205-8. doi: 10.2169/internalmedicine.54.3021. Epub 2015 Jan 15.

Growth factor treatment to overcome Alzheimer's dysfunctional signaling

Lauzon MA, Daviau A, Marcos B, Faucheux N.

Cell Signal. 2015 Jun;27(6):1025-38. doi: 10.1016/j.cellsig.2015.02.018. Epub 2015 Mar 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias